LMRI

+ Watchlist + Portfolio

Lumexa Imaging Holdings, Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $11.85
52-Week Range: $6.45 – $19.45
Market Cap: $1.12B
P/E (TTM): —
EPS (TTM): -0.29
Dividend Yield: —

Advanced Metrics

Price/Book: 1.82
PEG Ratio: —
Return on Equity: —
Return on Assets: —
Gross Margin: 14.81%
Operating Margin: 3.20%
Profit Margin: -2.66%
Current Ratio: 1.44
Debt/Equity: 1.59
Total Debt: $975.35M
Free Cash Flow: —
Revenue Growth: 5.10%
Earnings Growth: —
Enterprise Value: $2.03B

LMRI Income statement, annual periods, in USD
USD	FY2023	FY2024	FY2025
Revenue	$935.92M	$948.87M	$1.02B
Cost of Revenue	$836.96M	$852.61M	$865.52M
Gross Profit	$98.97M	$96.26M	$157.56M
Selling, General & Admin	$55.16M	$70.36M	$90.45M
Operating Expenses	$111.80M	$112.53M	$130.83M
Operating Income	-$12.83M	-$16.26M	$26.73M
EBITDA	$94.51M	$113.96M	$141.71M
Pretax Income	-$119.25M	-$79.19M	-$32.22M
Income Tax	$2.98M	$14.91M	$14.88M
Net Income	-$122.23M	-$94.10M	-$47.10M
Diluted EPS	-1.76	-1.35	-0.66
Diluted Shares	69.41M	94.57M	70.98M

LMRI Balance Sheet statement, annual periods, in USD
USD	FY2023	FY2024	FY2025
Cash & Equivalents	$20.19M	$26.13M	$58.83M
Receivables	$130.25M	$136.00M	$150.85M
Current Assets	$166.77M	$172.52M	$227.26M
Total Assets	$1.67B	$1.67B	$1.76B
Current Liabilities	$161.12M	$173.66M	$179.19M
Long-Term Debt	$1.18B	$1.19B	$819.03M
Total Debt	$1.30B	$1.31B	$962.50M
Total Liabilities	$1.47B	$1.51B	$1.18B
Retained Earnings	-$489.86M	-$583.96M	-$631.06M
Shareholders' Equity	$198.43M	$161.65M	$586.12M
Working Capital	$5.65M	-$1.14M	$48.07M
Net Debt	$1.18B	$1.17B	$774.91M

LMRI Cash Flow statement, annual periods, in USD
USD	FY2023	FY2024	FY2025
Operating Cash Flow	$37.51M	$40.73M	$17.07M
Capital Expenditure	-$24.01M	-$27.77M	-$23.48M
Free Cash Flow	$13.51M	$12.95M	-$6.40M
Depreciation & Amortisation	$72.07M	$57.13M	$55.39M
Stock-Based Compensation	$55.30M	$56.65M	$41.60M
Investing Cash Flow	-$29.66M	-$22.28M	-$20.96M
Financing Cash Flow	-$8.77M	-$12.50M	$36.58M
Share Repurchases	-$118.00K	$0.00	$0.00
Net Change in Cash	-$912.00K	$5.95M	$32.70M

LMRI Income statement, quarterly periods, in USD
USD	Q4 2024	Q1 2025	Q4 2025	Q1 2026
Revenue	$248.03M	$245.00M	$267.73M	$252.54M
Cost of Revenue	$226.46M	$208.40M	$225.62M	$217.75M
Gross Profit	$21.57M	$36.60M	$42.12M	$34.78M
Selling, General & Admin	$20.12M	$17.49M	$37.19M	$20.34M
Operating Expenses	$29.97M	$26.54M	$49.59M	$30.26M
Operating Income	-$8.40M	$10.06M	-$7.47M	$4.53M
EBITDA	$28.94M	$38.33M	$19.00M	$33.29M
Pretax Income	-$16.03M	-$4.31M	-$25.26M	$3.08M
Income Tax	$9.03M	$3.38M	$3.43M	$1.36M
Net Income	-$25.06M	-$7.69M	-$28.69M	$1.72M
Diluted EPS	—	-0.08	-0.38	0.02
Diluted Shares	—	94.57M	75.35M	95.98M

LMRI Balance Sheet statement, quarterly periods, in USD
USD	Q4 2024	Q1 2025	Q4 2025	Q1 2026
Cash & Equivalents	$26.13M	$191.00K	$58.83M	$51.23M
Receivables	$136.00M	$148.65M	$150.85M	$154.13M
Current Assets	$172.52M	$165.92M	$227.26M	$221.89M
Total Assets	$1.67B	$1.69B	$1.76B	$1.76B
Current Liabilities	$173.66M	$179.99M	$179.19M	$157.93M
Long-Term Debt	$1.19B	$1.18B	$819.03M	$816.97M
Total Debt	$1.31B	$1.31B	$962.50M	$967.45M
Total Liabilities	$1.51B	$1.52B	$1.18B	$1.16B
Retained Earnings	-$583.96M	-$602.37M	-$631.06M	-$629.34M
Shareholders' Equity	$161.65M	$167.11M	$586.12M	$599.62M
Working Capital	-$1.14M	-$14.07M	$48.07M	$63.95M
Net Debt	$1.17B	$1.20B	$774.91M	$780.88M

LMRI Cash Flow statement, quarterly periods, in USD
USD	Q4 2024	Q1 2025	Q4 2025	Q1 2026
Operating Cash Flow	$25.31M	-$13.96M	$17.10M	$2.93M
Capital Expenditure	-$5.87M	-$1.00M	-$4.25M	-$5.31M
Free Cash Flow	$19.44M	-$14.96M	$12.85M	-$2.38M
Depreciation & Amortisation	$13.58M	$12.79M	$16.24M	$13.88M
Stock-Based Compensation	$14.04M	$6.37M	$18.57M	$12.27M
Investing Cash Flow	-$5.58M	-$720.00K	-$2.40M	-$5.27M
Financing Cash Flow	-$4.93M	-$4.15M	$43.93M	-$5.26M
Net Change in Cash	$14.80M	-$18.83M	$58.64M	-$7.60M

Market Snapshot

About

Lumexa Imaging Holdings, Inc. is a medical imaging company focused on developing and deploying advanced imaging technologies and solutions. The company provides services and equipment related to diagnostic imaging for healthcare providers. Lumexa operates in the healthcare technology sector, supporting radiology and imaging departments. The company aims to improve patient care through innovative imaging solutions.